Literature DB >> 8406311

Recurrence of exocrine pancreatic cancer--local or hepatic?

J Westerdahl1, A Andrén-Sandberg, I Ihse.   

Abstract

The results of radical surgery for pancreatic cancer depend, like all other cancer surgery, on the technique used, and the biology of the disease. We have analysed the site and time of recurrence after pancreatectomy for exocrine pancreatic cancer in 74 patients who died more than six months postoperatively. All patients had recurrent disease, 64 patients had local recurrence in the pancreatic bed and 68 had liver metastases. Local recurrence without liver metastases was found in six patients, and ten had liver metastases, but no local recurrence. Both the time from operation to clinically evident recurrence and the postoperative survival time were significantly longer for patients with local recurrence only. Although not statistically significant, there was a tendency (5 out of 8) for smaller, well-differentiated tumors without spread outside the pancreas to be associated with local recurrences without liver metastases. We conclude that, in retrospect, the surgical procedures used were inappropriate and inadequate. To cure these patients, a more radical operation and/or effective adjuvant treatment is needed.

Entities:  

Mesh:

Year:  1993        PMID: 8406311

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  47 in total

Review 1.  Adjuvant therapy in pancreatic cancer.

Authors:  P Ghaneh; J Slavin; R Sutton; M Hartley; J P Neoptolemos
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Analysis of liver metastasis after resection for pancreatic ductal adenocarcinoma.

Authors:  Kwang Yeol Paik; Seong Ho Choi; Jin Seok Heo; Dong Wook Choi
Journal:  World J Gastrointest Oncol       Date:  2012-05-15

Review 3.  Oncological problems in pancreatic cancer surgery.

Authors:  Akimasa Nakao; Tsutomu Fujii; Hiroyuki Sugimoto; Naohito Kanazumi; Shuji Nomoto; Yasuhiro Kodera; Soichiro Inoue; Shin Takeda
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

4.  Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients.

Authors:  Katrin Hoffmann; Christiane Kerner; Wolfgang Wilfert; Marc Mueller; Joachim Thiery; Johann Hauss; Helmut Witzigmann
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

5.  Surgery for recurrent pancreatic ductal adenocarcinoma.

Authors:  Jörg Kleeff; Carolin Reiser; Ulf Hinz; Jeannine Bachmann; Jürgen Debus; Dirk Jaeger; Helmut Friess; Markus W Büchler
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

Review 6.  Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?

Authors:  Ruchika Gutt; Stanley L Liauw; Ralph R Weichselbaum
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-25

7.  Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio.

Authors:  Bolanle Asiyanbola; Ana Gleisner; Joseph M Herman; Michael A Choti; Christopher L Wolfgang; Michael Swartz; Barish H Edil; Richard D Schulick; John L Cameron; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2008-12-17       Impact factor: 3.452

8.  Aggressive secondary surgery for local recurrence of pancreatic cancer.

Authors:  Norihiro Shimoike; Takahisa Fujikawa; Hisatsugu Maekawa; Akira Tanaka
Journal:  BMJ Case Rep       Date:  2013-06-16

Review 9.  Re-adapting T cells for cancer therapy: from mouse models to clinical trials.

Authors:  Ingunn M Stromnes; Thomas M Schmitt; Aude G Chapuis; Sunil R Hingorani; Philip D Greenberg
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

10.  Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT.

Authors:  Cosimo Sperti; Claudio Pasquali; Sergio Bissoli; Franca Chierichetti; Guido Liessi; Sergio Pedrazzoli
Journal:  J Gastrointest Surg       Date:  2009-09-24       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.